APOE ε4’s impact on response to amyloid therapies in early symptomatic Alzheimer’s disease: Analyses from multiple clinical trials
In Alzheimer’s disease, the accumulation and aggregation of amyloid beta (Aβ) peptide into extracellular amyloid plaques is an early event that precedes neurodegeneration and functional and cognitive impairment. Genetic variants